See more : Cofidur S.A. (ALCOF.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Neptune Wellness Solutions Inc. (NEPT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neptune Wellness Solutions Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Heliogen, Inc. (HLGN-WT) Income Statement Analysis – Financial Results
- Harbin Pharmaceutical Group Co., Ltd. (600664.SS) Income Statement Analysis – Financial Results
- Jushi Holdings Inc. (JUSH.CN) Income Statement Analysis – Financial Results
- Graphex Group Limited (GRFXF) Income Statement Analysis – Financial Results
- FriendTimes Inc. (6820.HK) Income Statement Analysis – Financial Results
Neptune Wellness Solutions Inc. (NEPT)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.neptunewellness.com
About Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 52.62M | 61.01M | 44.49M | 29.58M | 24.44M | 27.65M | 43.22M | 22.63M | 15.07M | 19.50M | 25.95M | 19.25M | 17.06M | 12.05M | 10.32M | 7.60M | 6.28M | 4.01M | 1.66M | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 74.45M | 71.58M | 80.07M | 31.42M | 16.83M | 21.32M | 31.40M | 18.06M | 23.09M | 16.97M | 15.63M | 9.12M | 14.21M | 10.61M | 8.91M | 5.88M | 5.90M | 3.62M | 2.71M | 2.71M | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -21.84M | -10.58M | -35.58M | -1.84M | 7.61M | 6.32M | 11.82M | 4.57M | -8.02M | 2.52M | 10.31M | 10.13M | 2.85M | 1.43M | 1.41M | 1.72M | 382.33K | 398.16K | -1.05M | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | -41.51% | -17.34% | -79.96% | -6.22% | 31.15% | 22.88% | 27.34% | 20.18% | -53.20% | 12.93% | 39.75% | 52.64% | 16.68% | 11.91% | 13.69% | 22.57% | 6.09% | 9.92% | -62.95% | -62.95% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 484.22K | 1.10M | 2.43M | 2.94M | 7.29M | 15.30M | 6.69M | 7.14M | 9.98M | 8.53M | 8.18M | 3.93M | 2.59M | 2.61M | 487.30K | 362.29K | 338.33K | 155.71K | 175.82K | 597.55K | 647.78K | 419.88K | 103.26K | 103.26K |
General & Administrative | 0.00 | 0.00 | 89.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.60M | 26.52M | 15.32M | 9.86M | 736.02K | 461.05K | 2.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 357.74K | 18.06K | 18.06K |
Selling & Marketing | 0.00 | 0.00 | -19.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.45M | 2.24M | 2.41M | 2.10M | 0.00 | 0.00 | 2.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.83K | 11.83K | 0.00 |
SG&A | 46.42M | 75.81M | 81.62M | 62.16M | 15.29M | 15.30M | 15.75M | 13.75M | 23.63M | 32.00M | 18.15M | 11.96M | 736.02K | 461.05K | 4.52M | 2.65M | 2.65M | 0.00 | 0.00 | 1.17M | 1.01M | 369.57K | 18.06K | 18.06K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25M | 730.97K | 1.05M | 599.87K | 532.19K | 944.48K | 777.08K | 707.85K | 33.57K | 23.79K | 5.77K | 0.00 |
Operating Expenses | 46.91M | -92.30M | -122.78M | -53.99M | -30.42M | 2.48M | -6.34M | -15.99M | -20.84M | -24.77M | -29.26M | 15.90M | 4.57M | 3.80M | 5.61M | 3.54M | 1.28M | 932.80K | 883.67K | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
Cost & Expenses | 102.00M | -20.71M | -42.71M | -22.57M | -13.59M | 23.81M | 25.06M | 2.08M | 2.25M | -7.80M | -13.63M | 25.01M | 18.79M | 14.42M | 14.51M | 9.42M | 7.18M | 4.55M | 3.59M | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
Interest Income | 1.45K | 7.12K | 38.33K | 106.63K | 184.73K | 176.14K | 0.00 | 78.47K | 122.76K | 12.82K | 145.69K | 124.58K | 22.88K | 43.27K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 30.08K | 0.00 |
Interest Expense | 2.20M | 1.54M | 916.09K | 411.58K | 340.87K | 1.04M | -2.49M | 1.07M | 696.38K | 0.00 | 156.56K | 381.81K | 397.89K | 645.42K | 1.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 0.00 |
Depreciation & Amortization | 3.69M | 7.60M | 23.96M | 7.93M | 3.05M | 3.54M | 3.52M | 2.58M | 1.72M | 352.94K | 613.20K | 768.41K | 943.32K | 730.97K | 599.87K | 532.19K | 966.03K | 797.10K | 724.96K | 39.90K | 23.79K | -5.77K | -5.77K | 0.00 |
EBITDA | -63.05M | -79.89M | -95.65M | -58.94M | -11.84M | -18.99M | -4.88M | -13.19M | -39.51M | -37.27M | -14.86M | -4.87M | -3.41M | -1.59M | -3.34M | -1.11M | -950.60K | 324.37K | -1.20M | -1.76M | -1.66M | -789.45K | -121.32K | -121.32K |
EBITDA Ratio | -119.84% | -130.95% | -214.99% | -199.28% | -48.43% | -68.69% | -11.28% | -58.27% | -262.19% | -191.16% | -57.26% | -25.30% | -20.01% | -13.22% | -32.39% | -14.59% | -15.14% | 8.08% | -72.51% | -106.11% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -66.74M | -87.49M | -119.61M | -66.87M | -14.88M | -22.53M | -8.40M | -15.77M | -41.23M | -37.62M | -15.47M | -5.76M | -1.87M | -3.01M | -4.19M | -1.83M | -900.48K | -534.64K | -1.93M | -1.80M | -1.68M | -795.22K | -121.32K | -121.32K |
Operating Income Ratio | -126.85% | -143.41% | -268.84% | -226.08% | -60.89% | -81.50% | -19.44% | -69.67% | -273.60% | -192.97% | -59.63% | -29.94% | -10.96% | -25.01% | -40.61% | -24.02% | -14.34% | -13.32% | -116.18% | -108.51% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -53.28M | -17.02M | -40.94M | 10.61M | -8.14M | 30.23M | 11.38M | 3.01M | 11.65M | 15.38M | -3.49M | 138.13K | 2.63M | 1.55M | 2.30M | -184.53K | 1.94M | -61.91K | -1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | -120.02M | -105.55M | -160.55M | -56.26M | -23.02M | 7.70M | 2.98M | -12.76M | -29.58M | -22.24M | -18.96M | -5.63M | 760.09K | -1.46M | -1.89M | -2.01M | 115.69K | -596.54K | -1.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -228.11% | -173.01% | -360.85% | -190.22% | -94.19% | 27.85% | 6.91% | -56.37% | -196.27% | -114.06% | -73.08% | -29.22% | 4.46% | -12.12% | -18.31% | -26.45% | 1.84% | -14.86% | -119.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -38.31M | -11.82M | 4.37M | 4.60M | 170.01K | 1.64M | 2.17M | 1.93M | 245.09K | 0.00 | 1.00M | -1.01M | -2.25M | 645.42K | 620.39K | 678.09K | -95.65K | 873.96K | 603.31K | 628.25K | -12.48K | -18.54K | 5.77K | 121.32K |
Net Income | -81.71M | -93.73M | -154.80M | -60.86M | -23.19M | 17.53M | 6.38M | -7.47M | -27.96M | -16.64M | -16.77M | -4.62M | 527.52K | -1.46M | -4.81M | -2.50M | -804.82K | -1.41M | -2.59M | -2.43M | -1.67M | -765.13K | -121.32K | -121.32K |
Net Income Ratio | -155.30% | -153.64% | -347.93% | -205.77% | -94.88% | 63.41% | 14.77% | -33.01% | -185.54% | -85.35% | -64.64% | -24.00% | 3.09% | -12.12% | -46.62% | -32.95% | -12.82% | -35.08% | -156.24% | -146.35% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -138.09 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
EPS Diluted | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -140.00 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
Weighted Avg Shares Out | 295.31K | 120.61K | 86.54K | 64.27K | 56.81K | 56.14K | 55.68K | 53.36K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
Weighted Avg Shares Out (Dil) | 295.31K | 120.61K | 86.63K | 64.27K | 56.81K | 56.69K | 55.82K | 54.10K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
Neptune Provides Sprout Organics Distribution Update
Neptune Announces Amendment and Expansion of Sprout Secured Promissory Notes Led by Morgan Stanley
Neptune Wellness Solutions Inc. (NEPT) CEO Michael Cammarata on Q4 2022 Results - Earnings Call Transcript
Neptune Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results
Neptune Reschedules Release of Fourth Quarter and Full Year 2022 Financial Results and Date of Earnings Call
Neptune Wellness Solutions Inc. Closes $5 Million Registered Direct Offering
Why Neptune Wellness Solutions Shares Are Nosediving Today
Neptune Wellness Solutions Inc. Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Neptune Wellness Appoints Raymond Silcock as Chief Financial Officer
This Week's Cannabis Stock News: 7 Companies Make Headlines
Source: https://incomestatements.info
Category: Stock Reports